Cutler Group LP United Therapeutics Corp Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$174.81 - $241.14 $926,493 - $1.28 Million	-5,300 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$166.16 - $213.96 $149,544 - $192,564	900 Added 20.45%	5,300 $8,000
Q1 2021 Apr 26, 2021	BUY	$153.94 - $174.85 $677,336 - $769,340	4,400 New	4,400 $7,000
Q2 2018 Aug 10, 2018	SELL	$101.14 - $118.31 $303,420 - $354,930	-3,000 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$107.21 - $151.94 $192,978 - $273,492	1,800 Added 150.0%	3,000 $9,000
Q4 2017 Jan 17, 2018	SELL	$118.58 - $151.28 $533,610 - $680,760	-4,500 Reduced 78.95%	1,200 $1,000
Q3 2017 Oct 17, 2017	BUY	$114.6 - $136.81 $653,220 - $779,817	5,700	5,700 $20,000

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.